Product Images Lokelma

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Lokelma NDC 50090-6501 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - Figure 1

Figure 1 - Figure 1

figure_2 - Figure 2

figure_2 - Figure 2

The text lists various medications and their dosages including Lokelma, amlodipine, atorvastatin, clopidogrel, dabigatran, furosemide, glipizide, levothyroxine, triodothyronine, losartan, tacrolimus, and cyclosporin. The abbreviation "AUC" appears multiple times followed by "Cmax," which may refer to pharmacokinetic parameters. The final line of text contains ratios for the "LOKELMA + co-administered drug" compared to "co-administered drug alone."*

figure_3 - Figure 3

figure_3 - Figure 3

The text appears to be a table with serum potassium measurements at different doses for different groups of people. The groups include those taking a placebo and those taking doses of 5g, 10g and 15g of some substance. The table also includes the number of people in each group and their contributions to some primary endpoint. There are also two phases indicated, one an acute phase measured in hours and the other a randomized withdrawal phase measured in days. There are some missing values indicated with a plus sign. It is not clear what the substance being studied or the endpoint being measured are.*

Figure 4 - Figure 4

Figure 4 - Figure 4

figure_5 - image 01

figure_5 - image 01

Label Image - lbl500906501

Label Image - lbl500906501

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.